These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7846108)

  • 41. Implications of hepatic and extrahepatic metabolism of aspirin in selective inhibition of platelet cyclooxygenase.
    Roberts MS; Cossum PA; Kilpatrick D
    N Engl J Med; 1985 May; 312(21):1388-9. PubMed ID: 3921841
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of human platelet cyclooxygenase by alpha-tocopherol.
    Ali M; Gudbranson CG; McDonald JW
    Prostaglandins Med; 1980 Feb; 4(2):79-85. PubMed ID: 6771778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
    Ishikawa S; Manabe S; Wada O
    Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for measurement of platelet regeneration in man.
    Hamberg M; Svensson J; Blombäck M
    Prostaglandins Med; 1978 Dec; 1(6):455-60. PubMed ID: 104315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
    Maenthaisong R; Tacconelli S; Sritara P; Del Boccio P; Di Francesco L; Sacchetta P; Archararit N; Aryurachai K; Patrignani P; Suthisisang C
    Int J Immunopathol Pharmacol; 2013; 26(2):403-17. PubMed ID: 23755755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
    Gorczynska E; James M; Wegrzynowicz R; Masiak M
    Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
    [No Abstract]   [Full Text] [Related]  

  • 50. Recovery of cyclooxygenase activity after aspirin in populations of platelets separated on stractan density gradients.
    McDonald JW; Ali M
    Prostaglandins Leukot Med; 1983 Nov; 12(3):245-52. PubMed ID: 6419234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salicylate inhibition of antiplatelet effect of aspirin.
    Brantmark B; Hedner U; Melander A; Wåhlin-Boll E
    Lancet; 1981 Dec; 2(8259):1349. PubMed ID: 6118746
    [No Abstract]   [Full Text] [Related]  

  • 52. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspirin does not inhibit human megakaryocyte thromboxane synthesis in vivo.
    Huijgens PC; van den Berg CA; Imandt LM; Miltenburg A; Langenhuijsen MM
    Scand J Haematol; 1986 Jan; 36(1):92-5. PubMed ID: 3081996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).
    Titos E; Chiang N; Serhan CN; Romano M; Gaya J; Pueyo G; Clària J
    Am J Physiol; 1999 Nov; 277(5):C870-7. PubMed ID: 10564079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
    Roberts MS; McLeod LJ; Cossum PA; Vial JH
    Eur J Clin Pharmacol; 1984; 27(1):67-74. PubMed ID: 6436031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
    Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
    J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation.
    Nitelius E; Brantmark B; Fredholm B; Hedner U; Forshell GP; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1984; 27(2):165-8. PubMed ID: 6499897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salicylic acid retention impairs aspirin reactivity in type 2 diabetes.
    Zhang H; Xie H; Zheng X; Chai Y; Tang Z; Chen H; Li F; Christoph H; Chen J; Sun W; Ye H; Wang S; Hao H; Chen X
    Eur J Pharmacol; 2017 Jan; 794():234-245. PubMed ID: 27894813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.